Clinical Trial Update: China Stroke Secondary Prevention Trial [NA]

View source ↗

Summary

The China Stroke Secondary Prevention Trial has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: Xijing Hospital | Conditions: Stroke, Transient Ischemic Attack | NA | Status: WITHDRAWN